Hygeia Healthcare, a Chinese oncology healthcare group backed by Warburg Pincus, is planning to float shares on the Hong Kong Stock Exchange (HKEX) as the city board sees the appeal from healthcare and biotech companies for fund raising “rather strengthened” during the pandemic period.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
